Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK

Author:

Bain Stephen C.1,Bekker Hansen Brian2,Hunt Barnaby3ORCID,Chubb Barrie4,Valentine William J.3

Affiliation:

1. Diabetes Research Unit Cymru, Swansea University Medical School , Swansea , UK ;

2. Global Patient Access, Novo Nordisk A/S , Søborg , Denmark ;

3. Health Economics, Ossian Health Economics and Communications , Basel , Switzerland ;

4. External Affairs, Novo Nordisk Ltd , Gatwick , UK

Publisher

Informa UK Limited

Subject

Health Policy

Reference34 articles.

1. World Health Organization [Internet]. Global Report on Diabetes; 2016 [cited 2019 May 14]. Available from: https://www.who.int/diabetes/global-report/en/

2. Diabetes UK News [Internet] . Number of people with diabetes reaches 4.7 million; 2019 Feb 27 [cited 2019 May 14]. Available from: https://www.diabetes.org.uk/about_us/news/new-stats-people-living-with-diabetes.

3. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs

4. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

5. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3